Measuring antibiotic prescribing in hospitalised children in resource-poor countries: A systematic review

Journal of Paediatrics and Child Health

Volumn 49, Issue 3, 2013, Pages 185-192

  Irwin, Adam ^a   Sharland, Mike ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

antibiotic; antibiotic consumption; antimicrobial resistance; antimicrobial stewardship; children; defined daily dose; resource poor

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFAZOLIN; CEFTIZOXIME; CEPHALOSPORIN; COTRIMOXAZOLE; GENTAMICIN; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; CINAHL; DEVELOPING COUNTRY; DRUG EXPOSURE; DRUG USE; DRUG UTILIZATION; EMBASE; HOSPITAL PATIENT; HUMAN; MEDLINE; METHODOLOGY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, HOSPITALIZED; DEVELOPING COUNTRIES; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; HEALTH RESOURCES; HOSPITALS; HUMANS;

EID: 84874978730     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02126.x     Document Type: Review

References (52)

1. Rice LB, Eckstein EC, DeVente J, Shlaes DM,. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin. Infect. Dis. 1996; 23: 118-24.
2. Costelloe C, Metcalfe M, Lovering A, Mant D, Hay A,. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: a systematic review and meta-analysis. BMJ 2010; 340: c2096.
3. Goossens H, Ferech M, Stichele RV, Elseviers M,. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
4. Bruinsma N, Kristinsson KG, Bronzwaer S, et al,. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 2004; 54: 1045-50.
5. Melander E, Ekdahl K, Jonsson G, Molstad S,. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr. Infect. Dis. J. 2000; 19: 1172-7.
6. García-Rey C, Aguilar L, Baquero F, Casal J, Dal-Ré R,. Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 2002; 40: 159-64.
7. Sturkenboom MCJM, Verhamme KMC, Nicolosi A, et al,. Drug use in children: cohort study in three European countries. BMJ 2008; 337: a2245.
8. Raveh D, Levy Y, Schlesinger Y, Greenberg A, Rudensky B, Yinnon AM,. Longitudinal surveillance of antibiotic use in the hospital. Q. Med. J. 2001; 94: 141-52.
9. Bruinsma N, Hutchinson JM, van den Bogaard AE, Giamarellou H, Degener J, Stobberingh EE,. Influence of population density on antibiotic resistance. Epidemiol. Rev. 1996; 18: 10-28.
10. Ford-Jones EL, Friedberg J, McGeer A, et al,. Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement-a prospective study of 601 children in Toronto. Int. J. Pediatr. Otorhinolaryngol. 2002; 66: 227-42.
11. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE,. Trends in Antimicrobial Drug Development: Implications for the Future. Clin. Infect. Dis. 2004; 38: 1279-86.
12. Boucher HW, Talbot GH, Bradley JS, et al,. Bad Bugs, No Drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009; 48: 1-12.
13. Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H,. Ferech M and the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Groups. Emerging Infect. Dis. 2008; 14: 1722-30.
14. Okeke IN, Laxmiarayan R, Bhutta Z, et al,. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis. 2005; 5: 481-93.
15. Bryce J, Boschi-Pinto C, Shibuya K,. Black RE and the World Health Organisation Child Health Epidemiology Reference Group. Lancet 2005; 365: 1147-53.
16. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT,. Neonatal sepsis: an international perspective. Arch. Dis. Child. Fetal Neonatal Ed. 2005; 90: F220-4.
17. Tiskumara R, Fakharee SH, Liu CQ, et al,. on behalf of Asia-Pacific Neonatal Infections Study. Arch. Dis. Child. Fetal Neonatal Ed. 2009; 94: F144-8.
18. World Health Organisation. WHO Global Strategy for Containment of Antibiotic Resistance. Geneva: WHO, 2001.
19. European Conference on Antibiotic Use in Europe, Brussels, 15-17 November 2001. Final Report. Antwerp: ESAC-European Surveillance of Antimicrobial Consumption, 2002. Available from: http://www.esac.ua.ac.be[accessed 14 November 2009].
20. Ansari F, Erntell M, Goossens H, Davey P,. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin. Infect. Dis. 2009; 49: 1496-504.
21. Sharland M,. The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. J. Antimicrob. Chemother. 2007; 60 (Suppl. 1): i15-26.
22. Fehintola FA,. Pre-hospital and prescription use of antibacterial drugs at a secondary health centre in Ibadan, Nigeria. Afr. J. Pharm. Pharmacol. 2009; 3: 120-3.
23. Whitney CG, Klugman KP,. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin. Pediatr. Infect. Dis. 2004; 15: 86-93.
24. Okeke IN, Klugman KP, Bhutta ZA, et al,. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect. Dis. 2005; 5: 568-80.
25. World Health Organisation. World Health Assembly(fifty-first). Emerging and other communicable diseases: antimicrobial resistance. WHA51.17, 1998, agenda item 21.3.
26. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2010. Oslo, 2009.
27. Zhang W, Shen X, Wang Y, et al,. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol. Saf. 2008; 17: 306-11.
28. Zhang W, Shen X, Bergman U, et al,. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese hospitals (2002-2006). Int. J. Antimicrob. Agents 2008; 32: 250-5.
29. Ding H, Yang Y, Chen Y, Wang Y, Fan S, Shen X,. Antimicrobial use in paediatric intensive care units in China. Acta Paediatrica. 2008; 97: 100-4.
30. Ding H, Yang Y, Lu Q, et al,. Five-year surveillance of antimicrobial use in Chinese Pediatric Intensive Care Units. J. Trop. Pediatr. 2008; 54: 238-42.
31. Zhang W, Liu X, Wang Y, et al,. Antibiotic use in pulmonology wards of Chinese children's hospitals: 2002-2006. J. Clin. Pharm. Ther. 2009; 34: 61-5.
32. Ansari F,. Utilization review of systemic antiinfective agents in a teaching hospital in Tehran, Iran. Eur. J. Clin. Pharmacol. 2001; 57: 541-6.
33. Ebrahimzadeh MA, Shokrzadeh M, Ramezani A,. Utilization pattern of antibiotics in different wards of specialized Sari Emam University Hospital in Iran. Pak. J. Biol. Sci. 2008; 11: 275-9.
34. Hadi U, Duerink DO, Lestari ES, et al,. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin. Microbiol. Infect. 2008; 14: 698-707.
35. Musoki RN, Revathi G,. Emergence of multidrug-resistant Gram-negative organisms in a neonatal unit and the therapeutic implications. J. Trop. Pediatr. 2000; 46: 86-91.
36. Sáez-Llorens X, Castrejón de Wong MM, Castano E, de Suman O, de Morös D, de Atencio I,. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr. Infect. Dis. J. 2000; 19: 200-6.
37. Najdi AN, Khuffash FA, R'Shaid WA, Ateeqi WA,. Antibiotic misuse in a paediatric teaching hospital in Kuwait. Ann. Trop. Paediatr. 1988; 8: 145-8.
38. Shankar PR, Upadhyay DK, Subish P, Dubey AK, Mishra P,. Prescribing patterns among paediatric inpatients in a teaching hospital in western Nepal. Singapore Med. J. 2006; 47: 261-5.
39. Palikhe N,. Prescribing patterns of antibiotics in paediatric hospital of Kathmandu Valley. Kathmandu Univ. Med. J. 2004; 2: 6-12.
40. Rasamoelisoa JM, Tovone XG, Andriamady C, Rakotoarimanana DR,. Evaluation de l'utilisation des antibiotiques en milieu hospitalier pediatrique. Arch. Inst. Pasteur Madagascar 1999; 65: 124-6.
41. Akter FU, Heller D, Smith A, Rahman MM, Milly AF,. Antimicrobial use in paediatric wards of teaching hospitals in Bangladesh. Mymensingh Med. J. 2004; 13: 63-6.
42. Akter FU, Heller RD, Smith AJ, Milly AF,. Impact of a training intervention on use of antimicrobials in teaching hospitals. J. Infect. Dev. Ctries. 2009; 3: 447-51.
43. Thamlikitkul V, Danchaivijitr S, Kongpattanakul S, Ckokloikaew S,. Impact of an educational program on antibiotic use in a tertiary hospital in a developing country. J. Clin. Epidemiol. 1998; 51: 773-8.
44. Alausa OK, Montefiore D,. Bacterial infections, sensitivity patterns, and chemotherapy among hospital patients in the tropics. Scand. J. Infect. Dis. 1978; 10: 295-304.
45. Levy SB,. Antibiotic resistance: consequences of inaction. Clin. Infect. Dis. 2001; 33 (Suppl. 3): s124-9.
46. Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM,. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J. Antimicrob. Chemother. 2010; 65: 1270-5.
47. Townsend TR, Shapiro M, Rosner B, Kass EH,. Use of antimicrobial drugs in general hospitals: IV. Infants and children. Pediatrics 1979; 64: 573-8.
48. Kolár JV, Kadáková E,. Prescription of antimicrobial drugs to hospitalized children. Ann. Pharmacother. 1993; 27: 974-7.
49. van Houten MA, Luinge K, Laseur M, Kimpen JL,. Antibiotic utilisation for hospitalised patients. Int. J. Antimicrob. Agents 1998; 10: 161-4.
50. Potocki M, Goette J, Szucs TD, Nadal D,. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription. Infection 2003; 31: 398-403.
51. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, Levine GL, Goldmann DA, Jarvis WR,. Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr. Infect. Dis. J. 2005; 24: 766-73.
52. Henderson KL, Müller-Pebody B, Johnson AP, Goossens H,. Sharland M, on behalf of the ARPEC group. First set-up meeting for Antibiotic Resistance and Prescribing in European Children (ARPEC). Euro Surveill. 2009; 14: pii: 19404.